ESPR
Esperion Therapeutics Inc.

9,338
Mkt Cap
$805.13M
Volume
6.26M
52W High
$4.18
52W Low
$0.6925
PE Ratio
-6.38
ESPR Fundamentals
Price
$3.42
Prev Close
$3.34
Open
$3.34
50D MA
$3.55
Beta
1.15
Avg. Volume
5.13M
EPS (Annual)
-$0.2764
P/B
-1.56
Rev/Employee
$1.09M
Loading...
Loading...
News
all
press releases
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell?
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell...
MarketBeat·12d ago
News Placeholder
What is HC Wainwright's Estimate for ESPR FY2025 Earnings?
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Stock analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Esperion Therapeutics in a note issued to investors...
MarketBeat·13d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why...
MarketBeat·15d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Here's Why
Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - Should You Buy...
MarketBeat·19d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...
MarketBeat·25d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next?
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next...
MarketBeat·25d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Time to Sell?
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Here's What Happened...
MarketBeat·28d ago
News Placeholder
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) have earned an average rating of "Moderate Buy" from the eight research firms that are covering the stock, MarketBeat reports...
MarketBeat·1mo ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week High - Time to Buy?
Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest ESPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.